Jul 28, 2000
Guidant Announces Worldwide Market Release of the ZOOM Programming System
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable medical device systems, today announced the worldwide market release of the ZOOM(tm) Programming System. The ZOOM programmer is used by physicians and other clinicians to analyze data from Guidant cardiac rhythm management devices, such as the VENTAK(tm) PRIZM implantable defibrillator and the PULSAR(tm) MAX pacemaker. "The ZOOM Programming System defines new leadership standards in speed and ease-of-use for our physician customers and their clinician support staffs," said Fred McCoy, president of Guidant''s Cardiac Rhythm Management Group. The ZOOM Programming System literally brings a more intuitive, faster interface to the physician''s fingers. The features of the new programming system include: "The ZOOM Programming System is sleek; definitely a more user-friendly programmer to work with. Moreover, the intuitive touch screen interface makes it easier and faster for me to follow a patient''s implantable device," commented Neil Bernstein, M.D., attending physician of electrophysiology, assistant professor of medicine at New York University Medical Center. "The ZOOM programmer, with its speed and ease-of-use advantages, has the potential to generate significant time efficiencies for physicians and their staffs," McCoy noted. "The ZOOM Programming System is another compelling reason for physicians to select Guidant implantable defibrillators and pacemakers for their patients." Guidant will begin shipping the ZOOM Programming System this month. A global leader in the medical technology industry, Guidant Corporation provides innovative, minimally invasive and cost-effective products and services for the treatment of cardiovascular and vascular disease. For more information on Guidant''s products and services, visit the company''s web site at www.guidant.com.